How-To Geek on MSN4d
The Quiet Revolution of Synthetic Biology
Later, Wacław Szybalski popularized the term in 1974 in reference to genetic engineering, but little did he know that one day ...
BioWorld5d
At 5 years, TAVR as good as SAVR in low-risk patients
Medtronic plc’s Evolut Low-Risk trial continued to show non-inferiority of transcatheter aortic valve replacement to surgical aortic valve replacement in terms of death or disabling stroke at five ...
ahajournals.org3d
Evolution of Cardiac Damage Following SAVR in Asymptomatic Severe Aortic Stenosis
View all available purchase options and get full access to this article.